Clean Air And Sustainable Urban Planning As ‘Spatial Vaccines’ Against COVID-19 30/10/2020 Madeleine Hoecklin Second in a series– Cities that clean up their air quality, and promote other urban sustainability measures can help reduce residents’ risks during the COVID-19 pandemic as well as going forward, say a growing number of urban air quality and sustainability experts. That message was highlighted in two events last week and today, which were […] Continue reading -> “Long COVID” Haunts Many People After Their Recovery 30/10/2020 Svĕt Lustig Vijay It is “imperative” that governments recognize the long-term effects of COVID-19 and ensure that affected people can access health services, including primary health care as well as rehabilitation, emphasized the World Health Organization on Friday. “Although we are still learning about this virus, what’s clear is that this is not just a virus that kills […] Continue reading -> Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> COVID-19 And Neglected Tropical Diseases: Why We Must Fight Them In Tandem 28/10/2020 Mwelecele Ntuli Malecela It starts with a child bathing in a stream to escape scorching temperatures. Silently, beneath the water, larvae that have emerged from a tiny snail burrow into their leg before entering the bloodstream. Over the next few weeks, the larvae turn into adult worms which mate and produce hundreds of eggs every day. This is […] Continue reading -> Europe Becomes ‘Epicentre’ For COVID-19 As Spain Declares State Of Emergency & US Cases Rise 26/10/2020 Madeleine Hoecklin & J Hacker Spain announced a state of emergency on Sunday and ordered a nationwide curfew just days after becoming the first Western European country to surpass one million confirmed cases. The curfew and restrictions on gatherings of more than six people has made Spain the latest country in Europe to toughen its guidelines, after France placed 46 […] Continue reading -> Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Harnessing COVID-19 Innovations Could Revolutionize TB Care 23/10/2020 Madeleine Hoecklin In combatting COVID-19, many countries around the world are currently facing “house on fire moments,” as described by Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. However, the syndemic of COVID-19 and TB poses an even more deadly threat. TB and COVID-19 respiratory diseases affect mostly […] Continue reading -> Few COVID-19 Rapid Diagnostic Tests Meet WHO Standards For Accuracy – FIND Study 23/10/2020 Raisa Santos Rapid diagnostic tests (RDTs) could play a critical role in decentralising testing and reaching remote communities as WHO launches an Africa roll-out, but a recent study has found that only two of the six RDTs making it to the final round of testing met WHO accuracy standards. RDTs test for proteins produced by the SARS-CoV-2 […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Posts navigation Older postsNewer posts
“Long COVID” Haunts Many People After Their Recovery 30/10/2020 Svĕt Lustig Vijay It is “imperative” that governments recognize the long-term effects of COVID-19 and ensure that affected people can access health services, including primary health care as well as rehabilitation, emphasized the World Health Organization on Friday. “Although we are still learning about this virus, what’s clear is that this is not just a virus that kills […] Continue reading -> Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> COVID-19 And Neglected Tropical Diseases: Why We Must Fight Them In Tandem 28/10/2020 Mwelecele Ntuli Malecela It starts with a child bathing in a stream to escape scorching temperatures. Silently, beneath the water, larvae that have emerged from a tiny snail burrow into their leg before entering the bloodstream. Over the next few weeks, the larvae turn into adult worms which mate and produce hundreds of eggs every day. This is […] Continue reading -> Europe Becomes ‘Epicentre’ For COVID-19 As Spain Declares State Of Emergency & US Cases Rise 26/10/2020 Madeleine Hoecklin & J Hacker Spain announced a state of emergency on Sunday and ordered a nationwide curfew just days after becoming the first Western European country to surpass one million confirmed cases. The curfew and restrictions on gatherings of more than six people has made Spain the latest country in Europe to toughen its guidelines, after France placed 46 […] Continue reading -> Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Harnessing COVID-19 Innovations Could Revolutionize TB Care 23/10/2020 Madeleine Hoecklin In combatting COVID-19, many countries around the world are currently facing “house on fire moments,” as described by Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. However, the syndemic of COVID-19 and TB poses an even more deadly threat. TB and COVID-19 respiratory diseases affect mostly […] Continue reading -> Few COVID-19 Rapid Diagnostic Tests Meet WHO Standards For Accuracy – FIND Study 23/10/2020 Raisa Santos Rapid diagnostic tests (RDTs) could play a critical role in decentralising testing and reaching remote communities as WHO launches an Africa roll-out, but a recent study has found that only two of the six RDTs making it to the final round of testing met WHO accuracy standards. RDTs test for proteins produced by the SARS-CoV-2 […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Posts navigation Older postsNewer posts
Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> COVID-19 And Neglected Tropical Diseases: Why We Must Fight Them In Tandem 28/10/2020 Mwelecele Ntuli Malecela It starts with a child bathing in a stream to escape scorching temperatures. Silently, beneath the water, larvae that have emerged from a tiny snail burrow into their leg before entering the bloodstream. Over the next few weeks, the larvae turn into adult worms which mate and produce hundreds of eggs every day. This is […] Continue reading -> Europe Becomes ‘Epicentre’ For COVID-19 As Spain Declares State Of Emergency & US Cases Rise 26/10/2020 Madeleine Hoecklin & J Hacker Spain announced a state of emergency on Sunday and ordered a nationwide curfew just days after becoming the first Western European country to surpass one million confirmed cases. The curfew and restrictions on gatherings of more than six people has made Spain the latest country in Europe to toughen its guidelines, after France placed 46 […] Continue reading -> Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Harnessing COVID-19 Innovations Could Revolutionize TB Care 23/10/2020 Madeleine Hoecklin In combatting COVID-19, many countries around the world are currently facing “house on fire moments,” as described by Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. However, the syndemic of COVID-19 and TB poses an even more deadly threat. TB and COVID-19 respiratory diseases affect mostly […] Continue reading -> Few COVID-19 Rapid Diagnostic Tests Meet WHO Standards For Accuracy – FIND Study 23/10/2020 Raisa Santos Rapid diagnostic tests (RDTs) could play a critical role in decentralising testing and reaching remote communities as WHO launches an Africa roll-out, but a recent study has found that only two of the six RDTs making it to the final round of testing met WHO accuracy standards. RDTs test for proteins produced by the SARS-CoV-2 […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 And Neglected Tropical Diseases: Why We Must Fight Them In Tandem 28/10/2020 Mwelecele Ntuli Malecela It starts with a child bathing in a stream to escape scorching temperatures. Silently, beneath the water, larvae that have emerged from a tiny snail burrow into their leg before entering the bloodstream. Over the next few weeks, the larvae turn into adult worms which mate and produce hundreds of eggs every day. This is […] Continue reading -> Europe Becomes ‘Epicentre’ For COVID-19 As Spain Declares State Of Emergency & US Cases Rise 26/10/2020 Madeleine Hoecklin & J Hacker Spain announced a state of emergency on Sunday and ordered a nationwide curfew just days after becoming the first Western European country to surpass one million confirmed cases. The curfew and restrictions on gatherings of more than six people has made Spain the latest country in Europe to toughen its guidelines, after France placed 46 […] Continue reading -> Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Harnessing COVID-19 Innovations Could Revolutionize TB Care 23/10/2020 Madeleine Hoecklin In combatting COVID-19, many countries around the world are currently facing “house on fire moments,” as described by Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. However, the syndemic of COVID-19 and TB poses an even more deadly threat. TB and COVID-19 respiratory diseases affect mostly […] Continue reading -> Few COVID-19 Rapid Diagnostic Tests Meet WHO Standards For Accuracy – FIND Study 23/10/2020 Raisa Santos Rapid diagnostic tests (RDTs) could play a critical role in decentralising testing and reaching remote communities as WHO launches an Africa roll-out, but a recent study has found that only two of the six RDTs making it to the final round of testing met WHO accuracy standards. RDTs test for proteins produced by the SARS-CoV-2 […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Posts navigation Older postsNewer posts
Europe Becomes ‘Epicentre’ For COVID-19 As Spain Declares State Of Emergency & US Cases Rise 26/10/2020 Madeleine Hoecklin & J Hacker Spain announced a state of emergency on Sunday and ordered a nationwide curfew just days after becoming the first Western European country to surpass one million confirmed cases. The curfew and restrictions on gatherings of more than six people has made Spain the latest country in Europe to toughen its guidelines, after France placed 46 […] Continue reading -> Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Harnessing COVID-19 Innovations Could Revolutionize TB Care 23/10/2020 Madeleine Hoecklin In combatting COVID-19, many countries around the world are currently facing “house on fire moments,” as described by Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. However, the syndemic of COVID-19 and TB poses an even more deadly threat. TB and COVID-19 respiratory diseases affect mostly […] Continue reading -> Few COVID-19 Rapid Diagnostic Tests Meet WHO Standards For Accuracy – FIND Study 23/10/2020 Raisa Santos Rapid diagnostic tests (RDTs) could play a critical role in decentralising testing and reaching remote communities as WHO launches an Africa roll-out, but a recent study has found that only two of the six RDTs making it to the final round of testing met WHO accuracy standards. RDTs test for proteins produced by the SARS-CoV-2 […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Posts navigation Older postsNewer posts
Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Harnessing COVID-19 Innovations Could Revolutionize TB Care 23/10/2020 Madeleine Hoecklin In combatting COVID-19, many countries around the world are currently facing “house on fire moments,” as described by Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. However, the syndemic of COVID-19 and TB poses an even more deadly threat. TB and COVID-19 respiratory diseases affect mostly […] Continue reading -> Few COVID-19 Rapid Diagnostic Tests Meet WHO Standards For Accuracy – FIND Study 23/10/2020 Raisa Santos Rapid diagnostic tests (RDTs) could play a critical role in decentralising testing and reaching remote communities as WHO launches an Africa roll-out, but a recent study has found that only two of the six RDTs making it to the final round of testing met WHO accuracy standards. RDTs test for proteins produced by the SARS-CoV-2 […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Posts navigation Older postsNewer posts
Harnessing COVID-19 Innovations Could Revolutionize TB Care 23/10/2020 Madeleine Hoecklin In combatting COVID-19, many countries around the world are currently facing “house on fire moments,” as described by Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. However, the syndemic of COVID-19 and TB poses an even more deadly threat. TB and COVID-19 respiratory diseases affect mostly […] Continue reading -> Few COVID-19 Rapid Diagnostic Tests Meet WHO Standards For Accuracy – FIND Study 23/10/2020 Raisa Santos Rapid diagnostic tests (RDTs) could play a critical role in decentralising testing and reaching remote communities as WHO launches an Africa roll-out, but a recent study has found that only two of the six RDTs making it to the final round of testing met WHO accuracy standards. RDTs test for proteins produced by the SARS-CoV-2 […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Posts navigation Older postsNewer posts
Few COVID-19 Rapid Diagnostic Tests Meet WHO Standards For Accuracy – FIND Study 23/10/2020 Raisa Santos Rapid diagnostic tests (RDTs) could play a critical role in decentralising testing and reaching remote communities as WHO launches an Africa roll-out, but a recent study has found that only two of the six RDTs making it to the final round of testing met WHO accuracy standards. RDTs test for proteins produced by the SARS-CoV-2 […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Posts navigation Older postsNewer posts
Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Posts navigation Older postsNewer posts
Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Posts navigation Older postsNewer posts